European Companies Search Engine
Registration · Managing Director: Wolfgang Greb · Authorized signatory (ppa) (2) · Address · Capital: €25,200 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb14 Jan 2010 German Trade Register Announcements, Germany (08/01/2010)
Overview
Text
Pharma-Image Molecular Imaging Technologies GmbH,
Unnamed street ??, 41460 Neuss, Germany
. GmbH. Partnership agreement of December 8, 2009. Business address:
Unnamed street ??, 41460 Neuss, Germany
. Subject: Advising and conducting clinical trials using molecular imaging techniques of new active substances and diagnostics as well as innovative medicines, especially in the field of the central nervous system (psychiatry/neurology). Share capital: EUR 25,200.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. By decision of the shareholders' meeting, one or more directors may be granted the power to represent the company individually at all time. Any managing director may be exempted from the restrictions of the § 181 BGB by a shareholder decision. Managing Director: Dr.med. Dr.rer.nat. Greb, Wolfgang, Düsseldorf, *??.??.????, authorized to enter into legal transactions on behalf of the company with the authority to do legal transactions in its own name or a.s. a representative of a third party. Individual procuratorate: Prof. Dr. Gründer, Gerhard, Aachen, *??.??.????; Prof. Dr. ????, ????? ????, Jülich, *??.??.????.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Mind and Brain Institute GmbH, Zornheim, Germany.
